APA (7th ed.) Citation

Kaufmann, W. E., Sprouse, J., Rebowe, N., Hanania, T., Klamer, D., & Missling, C. U. (2019). ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Pharmacology, biochemistry and behavior, 187, 172796. https://doi.org/10.1016/j.pbb.2019.172796

Chicago Style (17th ed.) Citation

Kaufmann, Walter E., Jeffrey Sprouse, Nell Rebowe, Taleen Hanania, Daniel Klamer, and Christopher U. Missling. "ANAVEX®2-73 (blarcamesine), a Sigma-1 Receptor Agonist, Ameliorates Neurologic Impairments in a Mouse Model of Rett Syndrome." Pharmacology, Biochemistry and Behavior 187 (2019): 172796. https://doi.org/10.1016/j.pbb.2019.172796.

MLA (9th ed.) Citation

Kaufmann, Walter E., et al. "ANAVEX®2-73 (blarcamesine), a Sigma-1 Receptor Agonist, Ameliorates Neurologic Impairments in a Mouse Model of Rett Syndrome." Pharmacology, Biochemistry and Behavior, vol. 187, 2019, p. 172796, https://doi.org/10.1016/j.pbb.2019.172796.